FI905628A0 - Foerfarande foer framstaellning av nya terapeutiskt anvaendbara modifierade gangliosider och funktionella derivat daerav. - Google Patents

Foerfarande foer framstaellning av nya terapeutiskt anvaendbara modifierade gangliosider och funktionella derivat daerav.

Info

Publication number
FI905628A0
FI905628A0 FI905628A FI905628A FI905628A0 FI 905628 A0 FI905628 A0 FI 905628A0 FI 905628 A FI905628 A FI 905628A FI 905628 A FI905628 A FI 905628A FI 905628 A0 FI905628 A0 FI 905628A0
Authority
FI
Finland
Prior art keywords
gangliosider
functionella
daerav
derivat
och
Prior art date
Application number
FI905628A
Other languages
English (en)
Inventor
Valle Francesco Della
Aurelio Romeo
Original Assignee
Fidia Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fidia Spa filed Critical Fidia Spa
Publication of FI905628A0 publication Critical patent/FI905628A0/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07G—COMPOUNDS OF UNKNOWN CONSTITUTION
    • C07G99/00—Subject matter not provided for in other groups of this subclass
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/10—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical containing unsaturated carbon-to-carbon bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
FI905628A 1989-11-14 1990-11-14 Foerfarande foer framstaellning av nya terapeutiskt anvaendbara modifierade gangliosider och funktionella derivat daerav. FI905628A0 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT04855489A IT1238346B (it) 1989-11-14 1989-11-14 Gangliosidi modificati e loro derivati funzionali.

Publications (1)

Publication Number Publication Date
FI905628A0 true FI905628A0 (fi) 1990-11-14

Family

ID=11267289

Family Applications (1)

Application Number Title Priority Date Filing Date
FI905628A FI905628A0 (fi) 1989-11-14 1990-11-14 Foerfarande foer framstaellning av nya terapeutiskt anvaendbara modifierade gangliosider och funktionella derivat daerav.

Country Status (19)

Country Link
US (2) US5264424A (fi)
EP (1) EP0433112B1 (fi)
JP (1) JPH03170491A (fi)
KR (1) KR910009716A (fi)
CN (1) CN1033031C (fi)
AR (1) AR246527A1 (fi)
AT (1) ATE172737T1 (fi)
AU (1) AU645766B2 (fi)
BR (1) BR9005758A (fi)
CA (1) CA2029974A1 (fi)
DE (1) DE69032722T2 (fi)
ES (1) ES2124214T3 (fi)
FI (1) FI905628A0 (fi)
HU (1) HU210744B (fi)
IL (1) IL96344A0 (fi)
IT (1) IT1238346B (fi)
NO (1) NO174775C (fi)
NZ (1) NZ236057A (fi)
PL (1) PL287756A1 (fi)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6407072B1 (en) * 1988-12-02 2002-06-18 Fidia S.P.A. Lysoganglioside derivatives
IT1232176B (it) * 1989-07-27 1992-01-25 Fidia Farmaceutici Derivati di-lisogangliosidi
IT1239060B (it) * 1990-05-04 1993-09-20 Fidia Spa Processo per la modulazione selettiva dell'espressione e della funzione di un determinante sulla superficie cellulare attraverso appropriati agenti chimici
IT1253832B (it) * 1991-08-01 1995-08-29 Fidia Spa Derivati di gangliosidi
IT1267955B1 (it) * 1993-03-04 1997-02-18 Fidia S P A In Amministrazione Derivati solfatati dei lisogangliosidi
IT1267956B1 (it) * 1993-03-04 1997-02-18 Fidia S P A In Amministrazione Derivati o-solfatati di gangliosidi e lisogangliosidi
US5849717A (en) * 1993-03-04 1998-12-15 Fidia S.P.A. O-sulfated gangliosides and lyso-ganglioside derivatives
US5824662A (en) 1996-09-27 1998-10-20 Guilford Pharmaceuticals Inc. Treatment of global and focal ischemia using naaladase inhibitors
US6017903A (en) 1996-09-27 2000-01-25 Guilford Pharmaceuticals Inc. Pharmaceutical compositions and methods of treating a glutamate abnormality and effecting a neuronal activity in an animal using NAALADase inhibitors
NZ334780A (en) 1996-09-27 2000-12-22 Guilford Pharm Inc Use of a NAALADase inhibitor for treating glutamate abnormality and effecting neuronal activity in animals
US5973128A (en) * 1996-11-22 1999-10-26 The Hospital For Sick Children Research And Development Lp Glycolipid mimics and methods of use thereof
US8026280B2 (en) 2001-03-27 2011-09-27 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US6495719B2 (en) 2001-03-27 2002-12-17 Circagen Pharmaceutical Histone deacetylase inhibitors
US7842727B2 (en) 2001-03-27 2010-11-30 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US7312247B2 (en) 2001-03-27 2007-12-25 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
WO2003017949A2 (en) 2001-08-29 2003-03-06 Neose Technologies, Inc. Novel synthetic ganglioside derivatives and compositions thereof
WO2003099272A1 (en) 2002-05-22 2003-12-04 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors based on alpha-ketoepoxide compounds
EP1567142A4 (en) 2002-11-20 2005-12-14 Errant Gene Therapeutics Llc TREATMENT OF PULMONARY CELLS WITH HISTONE DEACETYLASE INHIBITORS
NZ567841A (en) 2003-03-06 2010-01-29 Seneb Biosciences Inc Methods and compositions for the enzymatic synthesis of gangliosides
WO2005033700A1 (ja) * 2003-10-03 2005-04-14 Takeda Pharmaceutical Company Limited インスリン抵抗性改善剤のスクリーニング方法
US7798041B2 (en) * 2004-04-15 2010-09-21 Milwaukee Electric Tool Corporation Miter adjustment assembly for a saw
US7932236B2 (en) * 2004-11-09 2011-04-26 Seneb Biosciences, Inc. Glycolipids
WO2009006613A1 (en) * 2007-07-03 2009-01-08 Children's Hospital & Research Center At Oakland Polysialic acid derivatives, methods of production, and uses in enhancing cancer antigen production and targeting
AU2008272792B2 (en) 2007-07-03 2014-03-06 Children's Hospital & Research Center At Oakland Oligosialic acid derivatives, methods of manufacture, and immunological uses
JP5597130B2 (ja) * 2007-07-03 2014-10-01 チルドレンズ ホスピタル アンド リサーチ センター アット オークランド ポリシアル酸脱ｎ−アセチラーゼの阻害剤及びその使用方法
US20120035120A1 (en) 2009-03-25 2012-02-09 Seneb Biosciences, Inc. Glycolipids as treatment for disease
CN109721632B (zh) * 2017-10-27 2023-10-31 齐鲁制药有限公司 一种高纯度神经节苷脂gm1及其制备方法
US20210353659A1 (en) * 2018-08-24 2021-11-18 Industry-Academic Cooperation Foundation, Yonsei University Composition for preventing or treating muscular diseases, or for improving muscular functions, containing gagnlioside

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1046051B (it) * 1975-08-13 1980-06-30 Fidia Spa Nuova applicazione terapeutica dei gangliosidi e procedimento per la loro estrazione
IT1171432B (it) * 1981-08-03 1987-06-10 Fidia Farmaceutici Amidi organiche derivate da lipidi azotati utilizzabili come farmaci
US4716223A (en) * 1981-08-04 1987-12-29 Fidia, S.P.A. Method for preparing ganglioside derivatives and use thereof in pharmaceutical compositions
US4476119A (en) * 1981-08-04 1984-10-09 Fidia S.P.A. Method for preparing ganglioside derivatives and use thereof in pharmaceutical compositions
US4593091A (en) * 1981-08-04 1986-06-03 Fidia, S.P.A. Method for preparing ganglioside derivatives and use thereof in pharmaceutical compositions
IT1199116B (it) * 1984-07-03 1988-12-30 Fidia Farmaceutici Derivati di gangliosidi
IT1182209B (it) * 1985-02-18 1987-09-30 Fidia Farmaceutici Uso terapeutico del monosialoganglioside gm1 e dei suoi derivati in gravi patologie di infarti cerebrali
IT1235161B (it) * 1988-12-02 1992-06-22 Fidia Farmaceutici Derivati di lisogangliosidi
IT1232176B (it) * 1989-07-27 1992-01-25 Fidia Farmaceutici Derivati di-lisogangliosidi

Also Published As

Publication number Publication date
ES2124214T3 (es) 1999-02-01
IT1238346B (it) 1993-07-13
IT8948554A0 (it) 1989-11-14
CN1051912A (zh) 1991-06-05
EP0433112A1 (en) 1991-06-19
NO174775B (no) 1994-03-28
IL96344A0 (en) 1991-08-16
DE69032722D1 (de) 1998-12-03
NO174775C (no) 1994-07-06
BR9005758A (pt) 1991-09-24
NO904921L (no) 1991-05-15
CN1033031C (zh) 1996-10-16
AU6662490A (en) 1991-05-23
US5424294A (en) 1995-06-13
NZ236057A (en) 1994-09-27
DE69032722T2 (de) 1999-07-08
AU645766B2 (en) 1994-01-27
HUT55403A (en) 1991-05-28
AR246527A1 (es) 1994-08-31
US5264424A (en) 1993-11-23
EP0433112B1 (en) 1998-10-28
ATE172737T1 (de) 1998-11-15
JPH03170491A (ja) 1991-07-24
HU210744B (en) 1995-07-28
PL287756A1 (en) 1991-12-02
IT8948554A1 (it) 1991-05-14
NO904921D0 (no) 1990-11-13
CA2029974A1 (en) 1991-05-15
KR910009716A (ko) 1991-06-28

Similar Documents

Publication Publication Date Title
FI905628A0 (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara modifierade gangliosider och funktionella derivat daerav.
FI900888A0 (fi) Foerfarande och anordning foer styrd lokal applicering av likstroempulser pao maennisko- och djurvaevnader.
FI923577A0 (fi) Anordning och foerfarande foer bestraolning av celler.
FI895910A0 (fi) Antiseptiska kompositioner och foerfarande foer deras framstaellning.
FI933705A0 (fi) Nya 4,5-dihydro-4-oxopyrrolo(1,2-a)kinoxaliner och motsvarande azaanaloger och foerfarande foer framstaellning av dessa
FI894515A (fi) Foerfarande och anordning foer styrning av en pappersbana pao en belaeggningsmaskin.
FI894717A0 (fi) Anordning foer maetning av lokalt och tidsavhaengigt upptraedande svaga biomagnetiska faelt i kroppen hos en patient.
FI911620A (fi) Kirurgisk sutur och foerfarande foer framstaellning daerav.
FI880213A (fi) System och foerfarande foer att foelja med vaottemperaturen i en roekgasstroem.
FI904838A0 (fi) Foerfarande foer framstaellning av farmaceutiskt aktiva karboxitetrahydroisokinoliner och deras derivat.
DE68914456D1 (de) Gewichtskontrollapparat.
FI890201A0 (fi) Foerfarande och anordning foer bestaemning av fukthalt i materialet.
FI883153A (fi) Foerfarande och anordning foer undersoekning av aemnens egenskaper.
FI890002A (fi) Foerfarande och anordning foer flyttning av lastutrymmet pao och fraon fordonet.
FI904283A0 (fi) Substituerade monoamider av glutarsyra och derivat daerav.
FI930293A (fi) Nya heteroaryloxi-b-karboliner, deras framstaellning och anvaendning i laekemedel
FI890517A (fi) Foerfarande och anordning foer befuktning av partiklar i gasstroemningen.
FI883680A (fi) Foerfarande foer behandling av illamaoende med vissa substituerade fenylalkylamino (och aminosyra) derivat.
FI925300A0 (fi) Nya kvaevehaltiga foereningar, foerfarande foer deras framstaellning och anvaendning av foereningarna
FI870783A0 (fi) Nya derivat baserade pao pyrido-menadion-additionsprodukter och deras anvaendning.
FI896347A0 (fi) Foerfarande och apparat foer diagnostisering av friktionssystem i motorer.
FI895205A0 (fi) Foerfarande foer upptagning av en ytterlapp pao en presskiva i en rullfoerpackningsmaskin och anordning foer tillaempning av foerfarandet.
FI905440A0 (fi) Foerfarande foer avskiljning av enantiomerer av benzopyranderivat.
FI894961A0 (fi) Foerfarande och anordning foer att faststaella laengdriktningen i flisbitar och liknande.
FI903023A0 (fi) Foerfarande foer anslutning av abonnenter via optiskt fiberkabelsystem till signalbehandlingsmedel i naetcentralen och optiskt naet enligt foerfarande.

Legal Events

Date Code Title Description
FD Application lapsed
FD Application lapsed

Owner name: FIDIA S.P.A.